http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2009143966-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e3f14575d0ba7180a1371b14fff340d5 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-196 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 |
| filingDate | 2009-03-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e34107fe6f3e45c3f5b08a17dcf3e3df |
| publicationDate | 2009-07-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2009143966-A |
| titleOfInvention | Pharmaceutical composition |
| abstract | 【Task】 The present invention provides a novel pharmaceutical composition, more specifically, a pharmaceutical composition useful as an anti-inflammatory composition. [Solution] It was newly found that when tranexamic acid or a salt thereof and clemastine or a salt thereof are used in combination, clemastine or a salt thereof enhances the anti-inflammatory effect of tranexamic acid or a salt thereof and exhibits an excellent anti-inflammatory effect. (1) An anti-inflammatory action-enhancing pharmaceutical composition comprising tranexamic acid and clemastine fumarate. (2) An anti-inflammatory effect enhancer of tranexamic acid, characterized by adding clemastine fumarate. [Selection figure] None |
| priorityDate | 2003-04-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 183.